Anticoagulant Safety: Monitoring Warfarin and DOACs in Care Settings

Anticoagulant medications prevent dangerous blood clots, but they do it by making a resident more prone to bleeding - which means small lapses in timing, monitoring, or awareness of interactions carry real consequences. Understanding the basics of how warfarin and the newer direct oral anticoagulants (DOACs) are managed differently is essential knowledge for any care team supporting residents on these medications.

Warfarin: why monitoring is central

Warfarin has been used for decades and works by interfering with vitamin K-dependent clotting factors. Because its effect varies significantly between individuals - and is affected by diet, illness, and interactions with other medications - it requires regular blood testing (INR, or International Normalised Ratio) to check the blood is neither too thin nor too thick, with the dose adjusted accordingly. Guidance summarised in resources such as the anticoagulants in care homes guidance emphasises that missed INR tests or delayed dose adjustments are a recurring, preventable source of harm in care settings.

DOACs: a different monitoring profile, not a monitoring-free one

DOACs - including apixaban, rivaroxaban, dabigatran and edoxaban - don't require the same routine blood-level monitoring as warfarin, which is part of why they've become widely used. But "no routine monitoring" doesn't mean "no monitoring at all": DOACs still need periodic kidney function checks, since they're cleared from the body via the kidneys and reduced kidney function can lead to dangerous drug accumulation. They're also far less forgiving of missed or late doses than warfarin, since their effect wears off more quickly - a missed dose can leave a resident under-protected sooner than a missed warfarin dose would.

What care staff need to know, regardless of which drug is prescribed

• Doses should be given at consistent times, and any missed or significantly delayed dose reported and documented - not silently skipped or "made up" without guidance
• Watch for signs of bleeding: unusual bruising, blood in urine or stool, prolonged bleeding from small cuts, nosebleeds that won't stop, or new severe headache
• Falls carry extra significance in a resident on anticoagulants, since even a minor knock can cause serious internal bleeding - any fall should be reported and monitored closely, not dismissed as trivial because no obvious injury is visible
• Be aware that many common over-the-counter medications, particularly NSAIDs like ibuprofen, increase bleeding risk when combined with anticoagulants and should never be given without checking first
• Know which specific anticoagulant each resident is on - warfarin and DOACs are managed differently, and mixing up guidance between the two can lead to real errors

Why falls and anticoagulants are a particularly important combination

This connects directly to good falls risk assessment practice - a resident on anticoagulant therapy who is also at elevated falls risk deserves extra vigilance, since the two risks compound each other. A fall that would be minor for most residents can become a genuine medical emergency for someone whose blood doesn't clot normally, making prompt reporting and observation after any fall especially important for this group.

Supporting safe, consistent administration

Anticoagulant safety is, at its core, an extension of good general medication management practice - consistent timing, careful checking, and clear escalation when something looks wrong. What makes anticoagulants different is simply how much less room for error they leave, which is exactly why building extra vigilance around them, rather than treating them like any other routine tablet, matters so much.

Handovers and communication matter

Because anticoagulant risk is cumulative and easy to lose track of across shifts, clear handover communication is genuinely protective. Flagging which residents are on anticoagulant therapy at the start of every shift, noting any recent dose changes, missed doses, falls, or new bruising, and making sure agency or new staff are briefed on who needs this extra vigilance all help prevent a gap in awareness turning into a missed warning sign. A simple, consistent way of flagging these residents in daily records - not relying on staff memory alone - makes this much easier to sustain over time.

Frequently asked questions

Do DOACs need any blood test monitoring at all? Yes - while they don't need the frequent INR checks warfarin requires, periodic kidney function tests are still needed, since reduced kidney function can cause dangerous drug build-up.

Should a minor fall in a resident on anticoagulants be treated differently? Yes - any fall in a resident on anticoagulant therapy should be reported and monitored closely, since bleeding risk means even apparently minor incidents can develop into something more serious.

Can care staff give over-the-counter painkillers to a resident on anticoagulants without checking? No - NSAIDs like ibuprofen significantly increase bleeding risk in combination with anticoagulants and should never be given without confirming it's safe for that specific resident first.

Confident, careful anticoagulant support protects residents from one of the more serious medication-related risks in care settings. Build this knowledge with CPD courses for care and healthcare staff.